REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ultra Chiron Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ultra Chiron Pharmaceuticals Pvt Ltd Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ultra Chiron Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 20/07/1993. It has its registered office in the State of Chandigarh, India. Company's corporate identification number (CIN) is U24231CH1993PTC013535 and registration number is 013535.

Legal Address
Plot No 80 Industrial Area Phase Ii
Chandigarh; Punjab; Postal Code: 160001

Contact Details: Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Ultra Chiron Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
July 20, 1993
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Ultra Chiron Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
30.15%▲
Total operating revenue
30.14%▲
Operating profit (EBIT)
-34.28%▼
EBITDA
-29.52%▼
Net Profit (Loss) for the Period
-55.15%▼
Total assets
16.94%▲
Total equity
4.24%▲
Operating Profit Margin (ROS)
-1.33%▼
Net Profit Margin
-1.3%▼
Return on Equity (ROE)
-5.38%▼
Quick Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo